All In Biotech

Drug Trial Radar · NCT07430956

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

A Master Protocol for a Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention With REGN7508 and REGN9933, Monoclonal Antibodies Against Factor XI, Versus Placebo in Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable (ROXI-INCLINE)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,628 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,628

Planned (sponsor's estimate)

Start

Apr 3, 2026

Primary completion

Mar 28, 2029

Study completion Jun 26, 2029

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Feb 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can slow down or pool in one spot, which can lead to the formation of blood clots. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how effective and safe REGN7508 and REGN9933, individually, are in preventing ischemic stroke or systemic embolism in people with atrial fibrillation who cannot or may choose to not take blood thinners. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well does REGN7508 or REGN9933 lower the risk of having an ischemic stroke and/or systemic embolism compared to the placebo * How well does REGN7508 or REGN9933 lower the risk of having a major health problem affecting heart and blood circulation compared to placebo * How well does REGN7508 or REGN9933 lower the risk of death compared to placebo * How much REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the study drugs less effective or could lead to side effects)

Conditions

  • Atrial Fibrillation (AF)

Interventions

  • REGN7508Drug

    Administered per the protocol

  • REGN9933Drug

    Administered per the protocol

  • PlaceboDrug

    Administered per the protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first occurrence of ischemic stroke or systemic embolismTime frame: Up to 36 months
  2. Time to first occurrence of International Society on Thrombosis and Haemostasis (ISTH) major bleedingTime frame: Up to 36 months

Locations

45 sites in 2 countries. Site status is shown where the registry gives one.

  • SEC Clinical Research

    Dothan, Alabama · Recruiting

  • Sun City Clinical Research

    Glendale, Arizona · Recruiting

  • Arkansas Cardiology P.A.

    Little Rock, Arkansas · Recruiting

  • Mission Cardiovascular Research Institute

    Fremont, California · Recruiting

  • National Institute of California Heart and Vein Specialists

    Huntington Beach, California · Recruiting

  • Profound Research LLC at San Diego Cardiovascular Associates

    La Jolla, California · Recruiting

  • Valley Clinical Trials, LLC dba Flourish Research

    Northridge, California · Recruiting

  • Profound Research LLC at Southern California Heart Specialists

    Pasadena, California · Recruiting

  • FOMAT - Comprehensive Cardiovascular Care

    Santa Maria, California · Recruiting

  • Cardiology Associates Medical Group

    Ventura, California · Recruiting

  • Interventional Cardiology Medical Group

    West Hills, California · Recruiting

  • East Coast Institute for Research, Jacksonville

    Jacksonville, Florida · Recruiting

  • South Florida Research Organization LLC

    Medley, Florida · Recruiting

  • Sec Clinical Research

    Pensacola, Florida · Recruiting

  • Cardiovascular Center of Sarasota Foundation for Research and Education

    Sarasota, Florida · Recruiting

  • Clinical Site Partners, LLC DBA Flourish Research

    Winter Park, Florida · Recruiting

  • Atlanta Clinical Research Centers

    Atlanta, Georgia · Recruiting

  • NSC Research, Inc

    Johns Creek, Georgia · Recruiting

  • Franciscan Physician Network, Indiana Heart Physicians

    Indianapolis, Indiana · Recruiting

  • Indiana Medical Research

    Merrillville, Indiana · Recruiting

  • Profound Research, Powers Health Medical Group - Electrophysiology

    Munster, Indiana · Recruiting

  • Monroe Research, LLC

    West Monroe, Louisiana · Recruiting

  • Profound Research, Cardiology and Vascular Associates (CAVA) - Bloomfield Hills

    Bloomfield Hills, Michigan · Recruiting

  • Profound Research, Millennium Cardiology

    Farmington Hills, Michigan · Recruiting

  • Flint Clinical Research

    Flint, Michigan · Recruiting

  • AA Medical Research Center (MRC)

    Flint, Michigan · Recruiting

  • Jackson Heart Clinic

    Jackson, Mississippi · Recruiting

  • Olive Branch Family Medical Center

    Olive Branch, Mississippi · Recruiting

  • Super Health Pharmacy

    Staten Island, New York · Recruiting

  • Hawthorne Health, Moose Pharmacy of Concord

    Concord, North Carolina · Recruiting

  • K&R Research LLC

    Marion, Ohio · Recruiting

  • AnMed Health

    Anderson, South Carolina · Recruiting

  • Monument Health Clinical Research

    Rapid City, South Dakota · Recruiting

  • Tennessee Center for Clinical Trials

    Tullahoma, Tennessee · Recruiting

  • PharmaTex Research

    Amarillo, Texas · Recruiting

  • PanAmerican Clinical Research

    Brownsville, Texas · Recruiting

  • Southwest Family Medicine Associates

    Dallas, Texas · Recruiting

  • East Texas Cardiology

    Houston, Texas · Recruiting

  • Synergy Group Medical,LLC

    Houston, Texas · Recruiting

  • Synergy Groups Medical

    Houston, Texas · Recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.